Spectrum Pharmaceuticals Inc
SPPI
SPPI was delisted on the 31st of July, 2023.
158 hedge funds and large institutions have $250M invested in Spectrum Pharmaceuticals Inc in 2020 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 60 increasing their positions, 37 reducing their positions, and 18 closing their positions.
62% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 37
49% more capital invested
Capital invested by funds: $167M → $250M (+$82.7M)
17% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 18
1% more funds holding
Funds holding: 156 → 158 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
42% less call options, than puts
Call options by funds: $197K | Put options by funds: $340K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$4.47M |
| 2 |
BlackRock
New York
|
+$3.21M |
| 3 |
D.E. Shaw & Co
New York
|
+$2.59M |
| 4 |
Renaissance Technologies
New York
|
+$2.17M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.75M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$6.68M |
| 2 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$3.53M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.34M |
| 4 |
Goldman Sachs
New York
|
-$749K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$564K |
SPPI Hedge Fund Activity: Q2 2020 in Review
158 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q2 2020, worth a combined $250M — up 49% from $167M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new SPPI positions and 18 closed out — a net gain of 3 holders — while 60 added to existing stakes and 37 trimmed.
The largest buyer was State Street, adding an estimated $4.47M. The largest seller was Morgan Stanley, cutting an estimated $6.68M.
- 158 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q2 2020, up from 156 in Q1 2020.
- Funds reported $250M of Spectrum Pharmaceuticals Inc stock for Q2 2020, up 49% quarter-over-quarter.
- 21 funds opened new Spectrum Pharmaceuticals Inc positions in Q2 2020 and 18 closed out, a net change of +3 holders.
- The largest Spectrum Pharmaceuticals Inc buyer in Q2 2020 was State Street, an estimated $4.47M added.
- The largest Spectrum Pharmaceuticals Inc seller in Q2 2020 was Morgan Stanley, an estimated $6.68M sold.
Based on aggregated 13F filings for Q2 2020.